Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Repurposing mitochondrial-targeting drugs for management of ICANS in CAR T-cell therapy: a novel steroid-sparing approach.
Journal: Frontiers in pharmacology
Published: May 31, 2026
Case Report: Fibrosis appearing as disease progression on PET/CT following R-CHOP in newly diagnosed DLBCL.
Journal: Frontiers in oncology
Published: April 02, 2026
Randomized Noninferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem-Cell Transplant Patients and Patients With Acute Leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 17, 2025
T-cell exhaustion due to BiTE therapy in multiple myeloma: mitigating infectious risks through treatment-free intervals.
Journal: Frontiers in immunology
Published: September 14, 2025
CAR T-cell therapy induced pseudoprogression.
Journal: Frontiers in immunology
Published: August 23, 2025
Soluble B-cell maturation antigen as a serum marker of MRD in patients with multiple myeloma.
Journal: Frontiers in oncology
Published: May 19, 2025
Case Report: Reactive T-cell large granular lymphocytes in the bone marrow of a patient with relapsed/refractory multiple myeloma receiving teclistamab.
Journal: Frontiers in oncology
Published: May 18, 2025
Prompt Autologous Hematopoietic Stem Cell Transplant in Patients With Large B-Cell Lymphoma Is Associated With Lower Rates of Progression of Disease Prior to Transplant.
Journal: EJHaem
Published: December 04, 2024
Radiomic features of PET/CT imaging of large B cell lymphoma lesions predicts CAR T cell therapy efficacy.
Journal: Frontiers in oncology
Published: August 23, 2024
Last Updated: 09/26/2026